Dose dependent effects of O2/O3 therapy on PSA levels of patient with risk of prostate cancer
Type: Original paper
Author: David Pakula A.P., DOM
When used in effective concentrations and dosages, systemic O2/O3 treatment can potentially be used as a complementary therapy for prostate cancer patients electing disease management by active surveillance. Further study is warranted.